Eukaryotic translation initiation factor 3 subunit K pseudogene 2 (EIF3KP2)

EIF3KP2 stands for *eukaryotic translation initiation factor 3 subunit K pseudogene 2*. It is classified as a **pseudogene**—a segment of DNA that resembles a gene but is non-functional; it does not encode a functional protein and is not known to be biologically active or implicated in human disease or as a therapeutic target. There is no documented role for EIF3KP2 as a receptor, enzyme, transporter, or other canonical drug target. There is also no evidence it functions as a biomarker, disease gene, or is associated with interacting drugs or safety concerns[2]. **Summary of findings:** - As a pseudogene, EIF3KP2 is typically not expressed as a protein and not considered a target in pharmacology, biotechnology, or medicine. - No disease relevance, functional biology, or clinical applications have been described for this pseudogene. - No drug interactions or therapeutic mechanisms are associated with EIF3KP2. **Conclusion:** EIF3KP2 is not a drug target or receptor, is classified as a pseudogene, and there are no known biological, disease, or therapeutic roles attributed to it. If you are seeking an actual protein-coding gene or a validated therapeutic target, this entry is likely not relevant[2].

Other names

EIF3KP2eukaryotic translation initiation factor 3, subunit K pseudogene 2